Ticagrelor-Induced Prolongation of the QTc Interval
Background. Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2019-01-01
|
| Serier: | Case Reports in Cardiology |
| Online adgang: | http://dx.doi.org/10.1155/2019/5984847 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|